Lacerta Therapeutics Company Overview, Contact Details & Competitors

Q: What is Lacerta Therapeutics's official website and social media links?

Lacerta Therapeutics's official website is lacertatx.com. Lacerta Therapeutics has social profiles on LinkedIn.

Q: How many employees does Lacerta Therapeutics have currently?

Lacerta Therapeutics has approximately 51 employees.

Q: What technology does Lacerta Therapeutics use?

Lacerta Therapeutics's tech stack includes Twemoji, Apache HTTP Server, Google Analytics, Elementor, YouTube.

Insights

Gathering insights about Lacerta Therapeutics…

Similar companies to Lacerta Therapeutics

Lacerta Therapeutics Tech Stack

Lacerta Therapeutics uses 8 technology products and services including WordPress, MySQL, Font Awesome, and more. Explore Lacerta Therapeutics's tech stack below.

WordPress
Content Management System
MySQL
Database
Font Awesome
Font Scripts
Swiper
Javascript Libraries
Slick
Javascript Libraries
PWA
Miscellaneous
Elementor
Page Builders
Apache
Web Servers

Media & News

Lacertatx hires Marc Wolff as Board of Directors.
Lacerta Therapeutics, Inc. a gene therapy company dedicated to the discovery and development of AAV-based gene therapies, appoints Min Wang, PhD, JD and Marc Wolff to its Board of Directors.
Apr 01, 2022 | lacertatx.com
Lacertatx hired Darin Falk as Chief Scientific Officer on Apr 2nd '22.
Lacerta Therapeutics, a preclinical-stage gene therapy company, announces an expansion in the executive leadership team: Kenneth Warrington, Jr., PhD, co-founder of Lacerta, has joined as the company’s Chief Technology Officer (CTO), and Darin Falk, PhD, former Vice President of Gene Therapy Programs at Lacerta, will now serve as the company’s Chief Scientific Officer (CSO).
Apr 01, 2022 | lacertatx.com
Lacertatx hired Kenneth Warrington, Jr. as Chief Scientific Officer on Apr 2nd '22.
Lacerta Therapeutics, a preclinical-stage gene therapy company, announces an expansion in the executive leadership team: Kenneth Warrington, Jr., PhD, co-founder of Lacerta, has joined as the company’s Chief Technology Officer (CTO), and Darin Falk, PhD, former Vice President of Gene Therapy Programs at Lacerta, will now serve as the company’s Chief Scientific Officer (CSO).
Apr 01, 2022 | lacertatx.com
Sarepta Therapeutics invested into Lacertatx $30M on Jan 1st '18.
Sarepta invested $30 million in Lacerta Therapeutics in 2018 and agreed last year to invest in partner StrideBio’s next financing round.
Oct 23, 2020 | www.bizjournals.com
Lacertatx received financing of $30M in investment round on Jan 1st '18.
UF Innovate | Sid Martin Biotech, the leading biotechnology incubator at the University of Florida, announces resident company Lacerta Therapeutics, Inc., has closed on a $30 million investment round.
Aug 12, 2018 | www.businesswire.com
Sarepta Therapeutics partnered with Lacertatx on Jul 10th '18.
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases, announced today that it has made a strategic investment and entered into a license and option agreement with Lacerta Therapeutics, a gene therapy company using a constellation of proprietary adeno-associated virus (AAV) vector technologies to develop CNS-targeted treatments and lysosomal storage diseases.
Aug 08, 2018 | globenewswire.com
Lacertatx receives financing of $500K in debt financing.
Lacerta Therapeutics was able to finance itself with $500,000.
Aug 07, 2018 | westmorelandtimes.com

Lacerta Therapeutics's Email Address Formats

Lacerta Therapeutics uses at least 1 format(s):

Lacerta Therapeutics Email Formats	Example	Percentage
FirstL@lacertatx.com	JohnD@lacertatx.com	42%
Last@lacertatx.com	Doe@lacertatx.com	10%
First@lacertatx.com	John@lacertatx.com	6%
FirstL@lacertatx.com	JohnD@lacertatx.com	42%

Frequently Asked Questions

What is Lacerta Therapeutics's phone number?

You can contact Lacerta Therapeutics's main corporate office by phone at

+1-352-514-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Lacerta Therapeutics's official website and social media links?

Lacerta Therapeutics's official website is lacertatx.com and has social profiles on LinkedIn Crunchbase.

What is Lacerta Therapeutics's SIC code NAICS code?

Lacerta Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Lacerta Therapeutics have currently?

As of December 2025, Lacerta Therapeutics has approximately 51 employees across 2 continents, including North AmericaAfrica. Key team members include Chief Technology Officer And Co-Founder: K. W.Director Capsid Engineering: V. T.Senior Director/Director, Aav Manufacturing, Mammalian Platform: P. C.. Explore Lacerta Therapeutics's employee directory with LeadIQ.

What industry does Lacerta Therapeutics belong to?

Lacerta Therapeutics operates in the Biotechnology Research industry.

What technology does Lacerta Therapeutics use?

Lacerta Therapeutics's tech stack includes WordPressMySQLFont AwesomeSwiperSlickPWAElementorApache.

What is Lacerta Therapeutics's email format?

Lacerta Therapeutics's email format typically follows the pattern of FirstL@lacertatx.com. Find more Lacerta Therapeutics email formats with LeadIQ.

How much funding has Lacerta Therapeutics raised to date?

As of December 2025, Lacerta Therapeutics has raised $30M in funding. The last funding round occurred on Aug 09, 2018 for $30M.

When was Lacerta Therapeutics founded?

Lacerta Therapeutics was founded in 2017.

Insights

Similar companies to Lacerta Therapeutics

Rocket Pharmaceuticals

Passage Bio

Sarepta Therapeutics

Amicus Therapeutics

AVROBIO

bluebird bio

Solid Biosciences

Lacerta Therapeutics Tech Stack

Media & News

Lacertatx hires Marc Wolff as Board of Directors.

Lacertatx hired Darin Falk as Chief Scientific Officer on Apr 2nd '22.

Lacertatx hired Kenneth Warrington, Jr. as Chief Scientific Officer on Apr 2nd '22.

Sarepta Therapeutics invested into Lacertatx $30M on Jan 1st '18.

Lacertatx received financing of $30M in investment round on Jan 1st '18.

Sarepta Therapeutics partnered with Lacertatx on Jul 10th '18.

Lacertatx receives financing of $500K in debt financing.

Lacerta Therapeutics's Email Address Formats

Frequently Asked Questions

What is Lacerta Therapeutics's phone number?

What is Lacerta Therapeutics's official website and social media links?

What is Lacerta Therapeutics's SIC code NAICS code?

How many employees does Lacerta Therapeutics have currently?

What industry does Lacerta Therapeutics belong to?

What technology does Lacerta Therapeutics use?

What is Lacerta Therapeutics's email format?

How much funding has Lacerta Therapeutics raised to date?

When was Lacerta Therapeutics founded?

Lacerta Therapeutics

Company Overview

Media & News

Lacertatx hires Marc Wolff as Board of Directors.

Lacertatx hired Darin Falk as Chief Scientific Officer on Apr 2nd '22.

Lacertatx hired Kenneth Warrington, Jr. as Chief Scientific Officer on Apr 2nd '22.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?